MedinCell S.A.
$34.39+0.00%(+$0.00)
TickerSpark Score
69/100
20
Valuation
60
Profitability
100
Growth
64
Health
100
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MDCLF research report →
52-Week Range100% of range
Low $6.98
Current $34.39
High $34.39
Companywww.medincell.com
MedinCell S. A. develops various therapeutic solutions.
- CEO
- Christophe Douat
- IPO
- 2021
- Employees
- 131
- HQ
- Jacou, FR
Price Chart
+392.69% · this period
Valuation
- Market Cap
- $1.23B
- P/E
- -44.68
- P/S
- 34.90
- P/B
- -29.10
- EV/EBITDA
- -53.69
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 58.12%
- Op Margin
- -44.96%
- Net Margin
- -71.98%
- ROE
- 84.89%
- ROIC
- -18.83%
Growth & Income
- Revenue
- $25.54M · 178.83%
- Net Income
- $-18,438,000 · 26.36%
- EPS
- $-0.63 · 28.41%
- Op Income
- $-10,840,000
- FCF YoY
- 235.78%
Performance & Tape
- 52W High
- $34.39
- 52W Low
- $6.98
- 50D MA
- $13.01
- 200D MA
- $8.48
- Beta
- 1.00
- Avg Volume
- 6
Get TickerSpark's AI analysis on MDCLF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our MDCLF Coverage
We haven't published any research on MDCLF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MDCLF Report →Similar Companies
BOVNF+0.00%
BioInvent International AB (publ)
$3.29
AVCTF-16.67%
Avacta Group Plc
$1.02
HLOSF+0.00%
Healios K.K.
$2.20
RAONF+113.11%
Race Oncology Limited
$2.60
PTCHF+0.00%
PureTech Health plc
$1.69
GSGTF+0.00%
GenSight Biologics S.A.
$0.19
NWBO-1.66%
Northwest Biotherapeutics, Inc.
$0.25
VRNOF+8.33%
Verano Holdings Corp.
$1.30